Stock analysis posts tagged "individual stock analysis" from Openbook.

This eli lilly stock analysis examines Q1 2026 earnings, the revenue contributions from Mounjaro, Zepbound and Foundayo, the growing oncology pipeline, dividend profile, balance sheet and current LLY valuation multiples. Understand the key drivers and risks shaping Eli Lilly's fundamental picture in 2026.

This Walmart stock analysis examines how WMT's grocery market dominance is fuelling a fast-growing retail media and membership business, with data from the Q1 FY27 earnings release (reported 21 May 2026) and full-year FY26 results.

This GSK stock analysis examines GlaxoSmithKline's Q2 2026 results, vaccines pipeline momentum, dividend cover and balance sheet position following the Nuvalent acquisition. Explore the key financial metrics and risks shaping the investment case in 2026.

This Broadcom stock analysis examines AVGO's Q2 FY2026 earnings, record AI chip revenue growth, balance sheet structure, dividend cover, and valuation multiples — so you can assess the fundamentals for yourself.

This SpaceX (SPCX) stock analysis examines the company's first public financials, covering 2025 revenue of $18.67 billion, segment results across Starlink, space and AI, and the valuation multiples applied after the record-breaking June 2026 IPO.

This Shell plc share price analysis examines the company's Q1 2026 earnings beat, dividend cover, balance sheet trends and the strategic implications of the ARC Resources acquisition. Explore the key financial signals and risks shaping the investment case for SHEL in 2026.

This rio tinto stock analysis examines the key financial metrics from Rio Tinto plc's (RIO) 2025 full year results, including iron ore margins, dividend cover, balance sheet leverage and valuation multiples. Understand the drivers, the risks and what to watch next.

This analysis covers Apple, Rolls-Royce, Meta Platforms, and Riot Platforms — breaking down the key financial drivers, valuation signals, and risks shaping each stock in 2026.